Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Xtalks Vitals Clinical Trials News

Pharmaceutical Biotech Medical Device Food Clinical Trials Drug Safety Pharmaceutical Marketing Life Science

Is an Expanded Indication Coming for Excelixis’ Cancer Drug?

October 18, 2017

San Francisco-based biotech Excelixis has posted positive results for its cancer drug cabozantinib, which may support an expanded indication for the drug in the treatment of advanced hepatocellular carcinoma (HCC).

Featured In: Clinical Trials News

Janssen’s iSTEP Mobile Clinical Trials Program Aims to Improve Medication Adherence

October 17, 2017 - Johnson & Johnson’s pharmaceutical division Janssen has developed a new mobile clinical trials platform to streamline clinical supply management and potentially improve patient reporting and medication adherence in these studies.

Featured In: Clinical Trial News

Axovant’s Alzheimer’s Drug Fails in Phase III Clinical Trial

September 27, 2017 - Swiss pharmaceutical company Axovant Sciences announced yesterday that their investigational Alzheimer’s disease drug intepirdine failed to meet its co-primary endpoints in a Phase III clinical trial.

Featured In: Clinical Trial News

Allergan’s Canadian Uterine Fibroid Registry Yields Better Understanding of Condition

September 19, 2017 - A patent registry launched by Allergan with the aim of collecting observational data from Canadian women diagnosed with uterine fibroids is reportedly the first of its kind to compile this kind of real-world data.

Featured In: Clinical Trial News


Cardiovascular Imaging for Monitoring Safety: Visualizing Outcomes

Treatment Allocation in Randomized Trials: Challenges and Best Practices

Will an Open-Access Clinical Trials Database Improve Drug Development?

September 18, 2017 - New Jersey-based business intelligence firm OZMOSI has launched a free-to-use, open-access database of clinical trial data collected from studies around the world.

Featured In: Clinical Trial News

First Oral Drug for Type 1 Diabetes Could be Available in 2018

September 15, 2017 - A type 1 diabetes drug being codeveloped by Lexicon Pharmaceuticals and Sanofi could be the first oral treatment approved for the autoimmune disease following the release of promising Phase III clinical trial results.

Featured In: Clinical Trial News

New Antibiotic Paired with Leukemia Treatment Lowers Infection Risk in Pediatric Patients

September 15, 2017 - Researchers at St. Jude Children’s Research Hospital have found an antibiotic that could help prevent patients from contracting these infections, without contributing to antibiotic resistance.

Featured In: Clinical Trial News

Onxeo Partners with Monopar Therapeutics on Development of Severe Oral Mucositis Drug

September 14, 2017 - After getting Validive (clonidine mucoadhesive buccal tablet), a drug designed to treat a common side effect of cancer treatment, through a Phase II clinical trial, Danish drugmaker Onxeo sought out a development partner for their candidate.

Featured In: Clinical Trials News

AstraZeneca Posts Favourable Results for First-in-Class Asthma Drug

September 11, 2017 - Results from AstraZeneca’s Phase IIb PATHWAY clinical trial suggest that the antibody drug tezepelumab could offer a new treatment option for patients with severe, uncontrolled asthma.

Featured In: Clinical Trials News

Clinical Trial Shows Amgen’s Repatha Does Not Impair Cognition

August 21, 2017 - Amgen’s PCSK9 inhibitor drug Repatha (evolocumab) does not have an effect on cognitive function, according to the results from a recent Phase III clinical trial.

Featured In: Clinical Trials News

Exclusion Criteria for Clinical Trials Poses Major Barrier to Patient Enrollment

August 17, 2017 - UT Southwestern researchers say that clinical investigators continue to increase the number of exclusion criteria, preventing more patients from participating in clinical trials.

Featured In: Clinical Trials News

Regeneron’s Drug for Respiratory Syncytial Virus Fails in Phase III Clinical Trial

August 16, 2017 - Biotechnology company Regeneron has announced it will not continue development of its antibody drug, suptavumab, after a failure in a Phase III clinical trial.

Featured In: Clinical Trials News

Type 1 Diabetes Could Eventually Be Treated Using Immunotherapy

August 11, 2017 - Researchers at the Cardiff University School of Medicine have found that an immunotherapy designed to treat diabetes was both safe and effective when tested in a small clinical trial.

Featured In: Clinical Trials News, Biotech News

Patient Anonymity in Clinical Trials Supported by Two De-Identification Methods

July 31, 2017 - A recent study – published Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research – looked at two de-identification methods for clinical trials data, known as k-anonymization and adding a “fuzzy factor.”

Featured In: Clinical Trials News

Approved Alzheimer’s Drug Could Reduce Inflammation in Patients with Metabolic Syndrome

July 28, 2017 - A recent report published in the journal JCI Insight suggests that an existing Alzheimer’s drug could also be used to treat patients with metabolic syndrome, a condition characterized by high blood pressure, elevated glucose levels, high cholesterol and excess fat around the midline.

Featured In: Clinical Trials News, Pharmaceutical News

Positive Clinical Trial Results Prompt Genocea to Push Herpes Drug into Phase III

July 26, 2017 - The data from Genocea Biosciences’ Phase IIb clinical trial for the company’s herpes drug candidate have just been released, and it looks like the biopharmaceutical firm will be pushing the immunotherapy into Phase III.

Featured In: Clinical Trials News

Insurance Coverage Under the Affordable Care Act Supports Clinical Trial Enrollment, Says Study

July 20, 2017 - Since the Patient Protection and Affordable Care Act (ACA) was passed in 2010, insurance approval for patients wishing to participate in oncology clinical trials has increased, according to a recent study published in the journal, Clinical Cancer Research.

Featured In: Clinical Trial News

CAR-T Cell Therapy Shows Promise as Leukemia Treatment in Early Stage Clinical Trial

July 19, 2017 - About 70 percent of clinical trial participants with chronic lymphocytic leukemia experienced tumor shrinkage after being treated with CAR-T immunotherapy, according to researchers at Fred Hutchinson Cancer Research Center.

Featured In: Clinical Trial News

Arena Pharmaceuticals’ Pulmonary Arterial Hypertension Drug Shows Positive Results in Clinical Trial

July 12, 2017 - San Diego-based company Arena Pharmaceuticals has released the results for their Phase II clinical trial of ralinepag, an investigational drug designed to treat pulmonary arterial hypertension (PAH).

Featured In: Clinical Trials News

Sorrento Therapeutics Gets FDA Go-Ahead for Cancer Pain Clinical Trial

July 5, 2017 - The FDA has authorized Sorrento Therapeutics’ Investigational New Drug Application (IND) for their chronic pain drug candidate, Resiniferatoxin (RTX).

Featured In: Clinical Trials News, Biotech News

Early Alzheimer’s Patients May See Benefit from Anti-Epilepsy Drug

June 27, 2017 - While the processes behind Alzheimer’s disease development aren’t fully understood, recent research has suggested that some cognitive decline could be caused by seizure-like activity in the brains of patients.

Featured In: Clinical Trials News

Merck Halts Enrollment in Keytruda Clinical Trials Following Patient Deaths

June 15, 2017 - Merck has announced that they will not be enrolling any new patients into two Phase III clinical trials involving Keytruda (pembrolizumab) following reports of patient deaths.

Featured In: Clinical Trials News, Drug Safety News

Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug

June 15, 2017 - Biopharmaceutical company Acceleron has announced their renal cell carcinoma (RCC) drug combo failed to meet its primary endpoint in a Phase II clinical trial, prompting the company to discontinue development of the candidate.

Featured In: Clinical Trials News

Reassessing Clinical Trials Outcome Measures for Fragile X Syndrome Treatments

June 13, 2017 - A recent review of 22 clinical trials testing new treatments for the genetic disease known as fragile X syndrome (FXS), has found that the use of more reliable outcome measures may be necessary in order to show treatment efficacy.

Featured In: Biotech News

Additional Insulin Injection May Reduce Heart Disease Risk in Patients with Type 1 Diabetes

June 6, 2017 - A small clinical trial conducted by researchers at the NIHR Newcastle Clinical Research Facility has found that patients with type 1 diabetes who were given an additional insulin injection three hours after consuming a meal may have a decreased risk of developing cardiovascular disease.

Featured In: Clinical Trials News

Handheld Medical Device to Improve Access to Cervical Cancer Screening

June 2, 2017 - Researchers at Duke University have developed a slim, handheld medical device that could revolutionize cervical cancer screening by putting the power in the hands of the women themselves.

Featured In: Medical Device News

GW Pharmaceuticals’ Cannabis Drug Show Promise in Late-Stage Clinical Trial of Epilepsy

May 30, 2017 - UK-based GW Pharmaceuticals has released positive Phase III clinical trial results for its cannabis-derived drug Epidiolex (cannabidiol) in children with a rare form of epilepsy.

Featured In: Clinical Trials News

Protagonist Therapeutics Starts Phase I Clinical Trial for Rare Diseases of Iron Overload

May 26, 2017 - A Phase I clinical trial of Protagonist Therapeutics’ biologic drug PTG-300, has commenced in a cohort of healthy volunteers.

Featured In: Clinical Trials News

Shire Releases Positive Late-Stage Clinical Trial Results for HAE Rare Disease Drug

May 19, 2017 - Dublin-based biotechnology company Shire is gearing up to submit a biologics license application (BLA) to the FDA after releasing positive data from its Phase III clinical trial of lanadelumab.

Featured In: Clinical Trials News, Biotech News

Load More News

INC Research and inVentiv Health Merge to Form CRO Worth $7.4 Billion

May 15, 2017 - The all-stock transaction is expected to be completed in the second half of this year.

Featured In: Clinical Trials News

Clinical Trial will Test Statins as Multiple Sclerosis Treatment

May 10, 2017 - The study coordinators plan to recruit over 1,000 patients with MS, and estimate the multi-year clinical trial will cost $7 million.

Featured In: Clinical Trials News

Endometrial Cancer Drug Fails in Late-Stage Clinical Trial

May 5, 2017 - Canadian biopharmaceutical company, Aeterna Zentaris, has announced that their investigational endometrial cancer drug failed to show a statistically significant increase in overall survival, compared to doxorubicin chemotherapy, in a recent late- stage clinical trial.

Featured In: Clinical Trials News

Medeor to Start Late-Stage Clinical Trial of Immunotherapy for Transplant Patients

May 1, 2017 - Medeor Therapeutics has just received the FDA go-ahead to start a clinical trial of its cell-based immunotherapy, MDR-101. The personalized therapeutic could replace immune-suppressing drugs in patients who have received an organ transplant.

Featured In: Clinical Trials News, Biotech News

AbbVie Posts Late-Stage Clinical Trial Results for Chronic Hepatitis C Drug

April 24, 2017 - Patients with a traditionally challenging to treat subtype of hepatitis C may soon have a new treatment option for the chronic infection.

Featured In: Clinical Trials News

Study: Few Cardiovascular Benefits of Aspirin Therapy for Patients with Peripheral Vascular Disease

April 24, 2017 - A new study conducted by researchers at the University of Florida has found that aspirin therapy may not provide sufficient cardiovascular benefits for patients with peripheral vascular disease.

Featured In: Clinical Trials News

Alternative Statistical Approach May Increase Patient-Centricity in Clinical Trials

April 18, 2017 - Researchers from the Massachusetts Institute of Technology (MIT), in collaboration with those from the Mayo Clinic, have published a study on the potential impact of including patient preferences in the traditional clinical trials process, on drug approvals in the oncology space.

Featured In: Clinical Trials News

Allergan’s Botox Enters Phase III Clinical Trial for Major Depressive Disorder

April 7, 2017 - Earlier this week, Dublin-based pharmaceutical company, Allergan, announced topline data from a Phase II clinical trial investigating the safety and efficacy of Botox to treat patients with Major Depressive Disorder (MDD).

Featured In: Clinical Trials News

Nektar’s Opioid Analgesic Meets Endpoints in Phase III Clinical Trial

March 28, 2017 - Nektar Therapeutics has announced that their opioid analgesic has met both its primary and secondary endpoint in a recent Phase III efficacy study.

Featured In: Clinical Trials News

FDA Approves New Drug for Parkinson’s Disease

March 23, 2017 - Newron Pharmaceuticals’ Xadago (safinamide) has been approved by the US Food and Drug Administration (FDA) as an add-on medication for patients with Parkinson’s disease.

Featured In: Clinical Trials News, Life Science News, Pharmaceutical News

Smartphone App Created Using Apple’s ResearchKit Used to Conduct Asthma Clinical Studies

March 22, 2017 - Researchers at the Icahn School of Medicine at Mount Sinai have conducted a large-scale, observational study of asthma patients using the Apple ResearchKit framework and the Asthma Health app on patients’ iPhones.

Featured In: Clinical Trials News

Trial Finds Oral Drug Could Become Standard of Care for In Vitro Fertilization

March 9, 2017 - Global healthcare and research company, Abbott, has announced the results of their phase III clinical trial assessing the efficacy of oral dydrogesterone in women undergoing in vitro fertilization (IVF).

Featured In: Clinical Trials News

Experimental Therapy for Midgut Neuroendocrine Tumors Investigated in Clinical Trial

March 1, 2017 - A new drug has been shown to improve progression-free survival in patients with rare midgut neuroendocrine tumors, according to researchers from Northwestern Medicine.

Featured In: Clinical Trials News

Merck’s Antiviral Drug Meets Primary Endpoint in Phase III Clinical Trial

February 28, 2017 - Merck’s investigational antiviral medicine, letermovir, has met its primary endpoint of reducing the incidence of cytomegalovirus (CMV) infection in adults following a bone marrow transplant.

Featured In: Clinical Trials News

ImmusanT Releases Phase I Clinical Trial Results for Celiac Therapeutic

February 24, 2017 - Massachusetts-based biotech company ImmusanT, has completed a Phase Ib clinical trial for its celiac disease vaccine, Nexvax2.

Featured In: Clinical Trials News

Antimicrobials Present on Healthy Skin Could Treat Atopic Dermatitis

February 24, 2017 - In studying the differences in microbial makeup of healthy and non-healthy skin, researchers from the University of California San Diego School of Medicine found that some beneficial bacterial naturally produce antimicrobial peptides, which could be used to treat patients with atopic dermatitis.

Featured In: Life Science News, Clinical Trials News

Interim Results for Lewy Body Dementia Drug Could Pave the Way for Phase III Clinical Trial

February 14, 2017 - So far, 11 patients have been treated with nelotanserin, and patients showed statistically significant improvements in extrapyramidal signs – such as tremor – compared to the placebo.

Featured In: Clinical Trials News

Clinical Trial on Effectiveness of Breast Cancer Screening Using 3D Mammography

February 9, 2017 - The Breast Health Center in Ottawa, Canada, is the latest site to join the lead-in to the Tomosynthesis Mammographic Imaging Screening Trial (TMIST).

Featured In: Clinical Trials News

Amgen’s Repatha Cholesterol Drug Cuts Risk of Cardiovascular Events in Clinical Trial

February 6, 2017 - Initial results from Amgen’s FOURIER clinical trial show that Repatha reduces the risk of cardiovascular events in patients with heart disease.

Featured In: Clinical Trials News

FDA Report Presents Case Studies on Clinical Trial Failures

January 27, 2017 - The report was meant to highlight the challenges associated with drug development, and the importance of the multistage drug approval process put in place by the FDA.

Featured In: Clinical Trials News

AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease

January 26, 2017 - AbbVie has commenced two Phase II clinical trials for the company’s investigational anti-tau antibody, ABBV- 8E12.

Featured In: Clinical Trials News, Biotech News

Celyad CAR-T Clinical Trial for Solid Tumors Underway

January 18, 2017 - In an effort to apply CAR-T immunotherapy to treat solid tumors, biotech company Celyad has started to enroll patients in its Phase Ib THINK clinical trial.

Featured In: Clinical Trials News

Allergan Plans to Submit to FDA After Positive Clinical Trial Results for Uterine Fibroid Drug

January 18, 2017 - Yesterday, global pharmaceutical company Allergan released positive Phase III clinical trial results for the company’s experimental treatment for uterine fibroids.

Featured In: Clinical Trials News

Second Phase III Clinical Trial for Valeant’s Psoriasis Drug Reports Positive Results

January 12, 2017 - Valeant Pharmaceuticals has announced positive results from their second pivotal Phase III clinical trial for their plaque psoriasis topical, IDP-118.

Featured In: Clinical Trials News

Roche’s Multiple Sclerosis Drug Shows Positive Results in Several Clinical Trials

January 12, 2017 - Three clinical trials have found that Roche’s multiple sclerosis (MS) drug, ocrelizumab, was associated with lower rates of disease progression in patients with progressive MS, and relapsing remitting MS.

Featured In: Clinical Trials News

Light Therapy Clinical Trial Shows Efficacy for Prostate Cancer

December 21, 2016 - Vascular-targeted photodynamic therapy (VTP) may be an effective treatment for low-risk prostate cancer, according to a recent phase III clinical trial led by researchers at University College London.

Featured In: Clinical Trials News

Biogen Releases Clinical Trial Data for Alzheimer’s Drug at CTAD Meeting

December 13, 2016 - Biotech company, Biogen, presented more positive data for its experimental Alzheimer’s disease drug, aducanumab, at the 9th Clinical Trials on Alzheimer's Disease (CTAD) meeting.

Featured In: Clinical Trials News

More Patient Deaths Put Hold on Juno’s CAR-T Immunotherapy Clinical Trial

November 29, 2016 - The Phase II clinical trial of Juno’s JCAR015 – named ROCKET – was voluntarily placed on hold following the adverse events.

Featured In: Clinical Trials News

Canadian Government Invests Millions in Stem Cell Research Projects

November 29, 2016 - This funding will be used to support 31 projects and clinical trials being conducted across Canada.

Featured In: Clinical Trials News, Biotech News

Celebrex Has Similar Risk Profile to Other NSAIDs, Could Be Sold Over-The-Counter

November 16, 2016 - Pfizer’s recently-completed PRECISION study aimed to compare the risk profile of its painkiller, Celebrex, with other nonsteroidal anti-inflammatory drugs (NSAIDs) including ibuprofen and naproxen.

Featured In: Clinical Trials News, Pharmaceutical News

Cholesterol-Lowering Biologic Shows Promise in Early-Stage Clinical Trial

November 16, 2016 - Research conducted at the University of Pennsylvania has found that a new injectable biologic drug may be effective at reducing triglyceride levels.

Featured In: Clinical Trials News, Biotech News

Cognition Therapeutics Initiates Phase Ib Clinical Trial for Alzheimer’s Drug

November 14, 2016 - The first Alzheimer’s patient has been dosed with an experimental small molecule drug in Cognition Therapeutics’ Phase Ib clinical trial.

Featured In: Clinical Trials News

High Blood Pressure Identified As Biomarker for PTSD Drug Response

November 10, 2016 - New findings suggest that soldiers with high blood pressure before taking medication for post-traumatic stress disorder (PTSD), may respond better to the treatment.

Featured In: Clinical Trials News

Clinical Trial Results Released For Herpes Vaccine

October 19, 2016 - Biotech company, Rational Vaccines has released promising data from their Phase I human clinical trial testing their Herpes vaccine candidate, Theravax.

Featured In: Clinical Trials News

Exelixis Presents Clinical Trial Results for Kidney Cancer Drug at ESMO

October 13, 2016 - According to data presented at this year’s European Society for Medical Oncology (ESMO) congress, Exelixis’ kidney cancer drug reduced the rate of disease progression or death in patients in a Phase II clinical trial, by 31 percent.

Featured In: Clinical Trials News

Clinical Trial Assesses Bioavailability Of New Form Of Vitamin B3

October 12, 2016 - The compound was found to be safe and effective as it boosts cellular levels of NAD+, thereby increasing energy production and protecting against oxidative stress and DNA damage.

Featured In: Clinical Trials News

Cempra Releases Promising Phase II Clinical Trial Results For Anti-NASH Drug

October 5, 2016 - Antibiotics developer Cempra Inc. has released positive interim results from a Phase II clinical trial for their drug, solithromycin, in the treatment of non-alcoholic steatohepatitis (NASH).

Featured In: Clinical Trials News

Comorbidity Could Be Key To Alzheimer’s Clinical Trial Failures

October 4, 2016 - Researchers estimate that up to 40 percent of Alzheimer’s patients also have vascular cognitive impairment and dementia.

Featured In: Clinical Trials News

Amgen’s Repatha Meets Primary And Secondary Endpoints In Phase III Clinical Trial

September 22, 2016 - Amgen’s PCSK9 inhibitor, Repatha met both its primary and secondary endpoints in a Phase III clinical trial testing the drug’s effects on coronary artery disease.

Featured In: Clinical Trials News

Aliskiren Tug-of-War Between Data Monitoring Committee and Regulatory Authorities

September 16, 2016 - A study called ATMOSPHERE (Aliskiren Trial to Minimize Outcomes in Patients with Heart Failure), involved over 7,000 heart failure patients that were assigned to one of three experimental groups.

Featured In: Clinical Trials News

Kannalife Sciences in Conjunction With Catalent Pharma Solutions to Test Cannabidiol For Encephalopathy

September 15, 2016 - Studies still on track after surprising new ruling from DEA.

Featured In: Clinical Trials News, Pharmaceutical News

FDA Grants Fast Track To Eli Lilly And AstraZeneca’s Alzheimer’s Drug

August 24, 2016 - The drug – developed by Eli Lilly and AstraZeneca – is a beta secretase cleaving enzyme (BACE) inhibitor that is currently being assessed in Phase III clinical trials.

Featured In: Clinical Trials News, Pharmaceutical Marketing News

Small Study Of Novartis Asthma Drug Shows Promising Results

August 9, 2016 - The results – which were published in the journal, The Lancet Respiratory Medicine – suggest that the drug could lower inflammatory biomarkers more effectively when compared to the placebo.

Featured In: Clinical Trials News, Pharmaceutical News

Early-Stage Clinical Trial Of NIH Zika Vaccine To Commence

August 8, 2016 - A Phase I clinical trial of an investigational new Zika vaccine is being organized by a branch of the National Institutes of Health (NIH), known as the National Institute of Allergy and Infectious Diseases (NIAID).

Featured In: Clinical Trials News

Pediatric Clinical Trials Often Discontinued Before Completion, Says Study

August 8, 2016 - Despite an increased push by federal regulators to encourage sponsors to conduct more pediatric clinical trials, a new study published in the journal, Pediatrics, suggests that many of these clinical trials are abandoned before they’re completed and study data is left unpublished.

Featured In: Clinical Trials News

FDA Concerned As Experimental Psoriasis Drug Linked To Suicide Risk

July 19, 2016 - During clinical trials of the treatment, six participants committed suicide but the FDA said a lack of data made it difficult to determine the events’ effect on drug safety

Featured In: Clinical Trials News, Drug Safety News

Ultragenyx Releases Positive Data From Phase III Rare Disease Clinical Trial

July 18, 2016 - California-based biotech, Ultragenyx, has posted broadly positive data from its late-stage clinical trial of the rare metabolic disorder, mucopolysaccharidosis 7 (MPS7).

Featured In: Clinical Trials News

Kite Pharma’s CAR-T Clinical Trial To Use Chemotherapy Drug Implicated In Patient Deaths

July 15, 2016 - In its upcoming clinical trial of their CAR-T therapy, Kite Pharma plans to use low-dose fludarabine as a preconditioning agent – a drug implicated in the death of three patients in a similar study conducted by Juno Therapeutics.

Featured In: Clinical Trials News, Biotech News

Update: Juno’s CAR-T Clinical Trial To Resume After FDA Rescinds Clinical Hold

July 14, 2016 - The US Food and Drug Administration (FDA) has lifted the clinical hold on a study of Juno Therapeutics’ lead CAR-T therapy, which will allow the biotech company to resume enrollment.

Featured In: Clinical Trials News

New Drug For Postpartum Depression On The Horizon

July 13, 2016 - Biotech company Sage Therapeutics has announced that their experimental postpartum depression drug was able to relieve symptoms in 70 percent of patients.

Featured In: Clinical Trials News, Pharmaceutical News

FDA Stops Juno’s CAR-T Clinical Trial After Death Of 3 Patients

July 11, 2016 - Immunotherapy developer Juno Therapeutics, in compliance with the US Food and Drug Administration (FDA), has halted a clinical trial of an experimental CAR-T cell therapy after three patients died as a result of the treatment.

Featured In: Clinical Trials News

Seres Therapeutics To Conduct First Clinical Trial Of Synthetic Microbiome Drug

July 8, 2016 - Microbiome therapeutics company Seres has announced it has started a Phase Ib clinical trial of its SER-262 oral microbiome therapy.

Featured In: Clinical Trials News, Biotech News

Sanofi Partners With US Army To Push Zika Vaccine Into Clinical Trials

July 7, 2016 - Global vaccines company Sanofi Pasteur has announced a partnership with the U.S. Army's Walter Reed Army Institute of Research (WRAIR) to co-develop a Zika vaccine candidate.

Featured In: Clinical Trials News

Inovio’s Zika Vaccine Enters Early Clinical Trials

June 22, 2016 - Inovio Pharmaceuticals plans to start a Phase I clinical trial of its experimental Zika vaccine in the next few weeks.

Novo Nordisk’s Diabetes Drug Becomes Second Ever To Show Cardiovascular Benefit

June 16, 2016 - A recent clinical trial found that Novo Nordisk’s diabetes medication Victoza – an injectable GLP-1 receptor agonist – reduced the risk of cardiovascular episodes by 13 percent.

FDA Commissioner Wants To Build Preclinical Database

June 13, 2016 - Robert Califf, the commissioner of the US Food and Drug Administration (FDA) thinks an official database for preclinical studies should be established in order to help improve transparency in basic research.

Study Suggests Most Antidepressants Are Ineffective For Young Patients

June 10, 2016 - Many antidepressants are ineffective at treating children and young adults suffering from major depression, according to a recent meta-analysis of published data.

Diagnostic Device Rapidly Diagnoses Heart Attack

June 7, 2016 - A new diagnostic device designed by Philips is able to quickly diagnose patients who have experienced a heart attack, at the point-of-care.

Healthcare Consortium To Match Patients To Clinical Trials Via Data Sharing

June 7, 2016 - Medical Centers from around the country – including Stanford Cancer Institute, Intermountain Healthcare, Providence Health & Services and Syapse – have founded a consortium aimed at using data sharing to improve patient access to cancer clinical trials.

Daiichi Sankyo Abandons Phase III Clinical Trial Of Lung Cancer Drug

June 3, 2016 - The decision was based on a recommendation from an independent data monitoring committee which found the drug failed to be effective against non-small cell lung cancer.

Oramed’s Oral Insulin Clinical Trial Meets Primary Endpoint

May 19, 2016 - Looking to cash-in on the potentially $15 billion oral insulin market, Oramed is trying to beat Novo Nordisk to launch the first oral insulin product on the market.

Could Anonymized Healthcare Data Pose A Risk To Patient Privacy?

May 17, 2016 - According to a recent paper in the journal, Anesthesia & Analgesia, this practice of data sharing could be a threat to patient privacy.

CAR-T Cell Immunotherapy Leads To 90 Percent Remission Rate In Leukemia Clinical Trial

May 9, 2016 - The trial – which took ten months to complete – resulted in a complete remission rate of 90 percent, and a minimal residual disease (MRD-negative) rate of 80 percent.

LUNGevity Launches Lung Cancer Program To Help Clinical Trial Participants

May 2, 2016 - National nonprofit organization LUNGevity, is launching a Clinical Trial Ambassador Program aimed at connecting fist-time lung cancer trial participants with patients who have previously been part of a trial.

Gene Therapy Clinical Trial For Rare Neurodegenerative Disorder Commences

April 29, 2016 - Nationwide Children’s Hospital has just started a first-in-human clinical trial testing the effectiveness of gene therapy at treating the rare neurodegenerative disorder, Batten disease CLN6.

FDA Requires Additional Trials For Catalyst Pharmaceuticals’ Rare Disease Drug

April 28, 2016 - Just two months after Catalyst Pharmaceuticals received a rarely-issued Refuse to File letter from the US Food and Drug Administration (FDA), the biotech has faced more hurdles with the regulatory agency.

CAR-T Cell Immunotherapy Could Be Viable Treatment For Some Brain Cancers

April 25, 2016 - A Phase I clinical trial testing whether CAR-T cell immunotherapy could be a viable treatment for a type of brain cancer known as glioblastoma, has found that the therapy was both safe and effective.

Generic Drug Could Reverse Vision Loss Due To Multiple Sclerosis

April 15, 2016 - In a mid-stage trial, patients taking the antihistamine showed improved eye-to-brain signaling, compared to those on the placebo.

AstraZeneca and Eli Lilly Pursue Late-Stage Clinical Trial For Alzheimer’s Drug

April 11, 2016 - Pharmaceutical powerhouses AstraZeneca and Eli Lilly have announced that they will be pushing their experimental Alzheimer’s candidate into a Phase III clinical trial.

Celldex Therapeutics Terminates Phase III Clinical Trial For Brain Cancer Vaccine

March 9, 2016 - On Monday, biotech company Celldex Therapeutics announced they would be prematurely ending the Phase III clinical trial for their glioblastoma vaccine, Rintega.

Exposure To Peanuts Builds Tolerance In Children, Potentially Preventing Allergy

March 8, 2016 - A new study published in the prestigious New England Journal of Medicine, suggests that feeding infants peanut products can prevent them from developing serious allergies to the food during childhood.

ScPharmaceuticals Sees Phase III Clinical Trial Success Of Subcutaneous Antibiotic and Pump

March 7, 2016 - Massachusetts-based scPharmaceuticals reported promising Phase III clinical trial results for its sc2Wear Pump: a wearable device designed to administer subcutaneous antibiotics.

Amgen and UBC Get Osteoporosis Drug Through Phase III Clinical Trial

February 26, 2016 - Amgen’s osteoporosis drug – romosozumab – has shown promising results in a Phase III clinical trial.

Flexion’s Osteoarthritis Painkiller Passes Phase III Clinical Trial

February 18, 2016 - Flexion Therapeutics’ has announced the success of its osteoarthritis drug in a Phase III clinical trial.

Study Finds Pfizer’s Smoking Cessation Drug, Chantix, Is No More Effective Than Nicotine Patches

February 8, 2016 - A new study published in the Journal of the American Medical Association (JAMA), found that there was no statistically significant difference in quit smoking rates between individuals using nicotine patches, lozenges or taking Pfizer’s Chantix.

Update: Investigation Continues Into Cause of Deadly French Drug Clinical Trial

February 8, 2016 - Investigators in France are still trying to determine why a Phase I clinical trial – conducted last month – left one person dead and five others seriously injured.

Alkermes Depression Drug Fails Phase III Clinical Trial

January 26, 2016 - A new depression drug – ALKS-5461 – in development by biopharmaceutical company Alkermes, has failed the first two of three Phase III clinical trials.

French Drug Trial Leaves One Participant Brain Dead, Five Others Seriously Ill

January 19, 2016 - During a Phase I clinical trial run by French drug evaluation company, Biotrial, six participants became critically ill – one of which has now been declared brain dead.

Elsevier Launches New Open Access Journal For Clinical Trial Professionals

January 11, 2016 - Elsevier Launches New Open Access Journal For Clinical Trial Professionals

Copyright © 2016-2017 Honeycomb Worldwide Inc.